As big pharma exits Nigeria, asthma patients face spiralling costs

Price of asthma inhalers has more than doubled amid scarcity and added costs after GSK exited Nigerian market in 2023.

from Al Jazeera – Breaking News, World News and Video from Al Jazeera https://ift.tt/ztTY7IM